Harbin Gloria Pharmaceuticals Cash Flow Conversion Efficiency

Latest as of September 2025: 0.084x

Harbin Gloria Pharmaceuticals cash flow conversion efficiency. Based on the latest financial reports, Harbin Gloria Pharmaceuticals (002437) has a cash flow conversion efficiency ratio of 0.084x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.89 Million ≈ $26.76 Million USD) by net assets (CN¥2.18 Billion ≈ $318.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Harbin Gloria Pharmaceuticals (2007–2025)

Cash flow conversion efficiency of Harbin Gloria Pharmaceuticals from 2007 to 2025. This chart illustrates how Harbin Gloria Pharmaceuticals's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002437 stock price and chart for real-time trading data and today's change.

Harbin Gloria Pharmaceuticals Cash Flow Conversion Ratio Explained

Harbin Gloria Pharmaceuticals cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Harbin Gloria Pharmaceuticals Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Gloria Pharmaceuticals ranked by their cash flow conversion efficiency. Also see 002437 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
Superior Plus Corp TO:SPB	0.408x
Guangxi Liuzhou Pharm Co Ltd SHG:603368	0.006x
Rigol Technologies Co. Ltd. A SHG:688337	N/A
Akasha Wira International Tbk JK:ADES	0.056x
Yueyang Forest & Paper Co Ltd SHG:600963	-0.032x
Anhui Andeli Department Store Co Ltd SHG:603031	0.085x
Redcare Pharmacy NV F:RDC	-0.039x

Annual Cash Flow Conversion Efficiency for Harbin Gloria Pharmaceuticals (2007–2025)

The table below shows the annual cash flow conversion efficiency of Harbin Gloria Pharmaceuticals from 2007 to 2025. Review 002437 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.31 Billion ≈ $337.96 Million	CN¥273.36 Million ≈ $40.00 Million	0.118x	-43.18%
2024-12-31	CN¥1.97 Billion ≈ $288.69 Million	CN¥410.94 Million ≈ $60.13 Million	0.208x	+29.93%
2023-12-31	CN¥1.71 Billion ≈ $250.26 Million	CN¥274.18 Million ≈ $40.12 Million	0.160x	+4.39%
2022-12-31	CN¥1.70 Billion ≈ $249.28 Million	CN¥261.62 Million ≈ $38.28 Million	0.154x	+10.84%
2021-12-31	CN¥1.98 Billion ≈ $289.58 Million	CN¥274.18 Million ≈ $40.12 Million	0.139x	+1998.19%
2020-12-31	CN¥1.93 Billion ≈ $282.85 Million	CN¥12.76 Million ≈ $1.87 Million	0.007x	-98.28%
2019-12-31	CN¥1.59 Billion ≈ $232.45 Million	CN¥610.37 Million ≈ $89.32 Million	0.384x	+45.20%
2018-12-31	CN¥4.39 Billion ≈ $642.95 Million	CN¥1.16 Billion ≈ $170.15 Million	0.265x	+72.66%
2017-12-31	CN¥4.25 Billion ≈ $622.28 Million	CN¥651.80 Million ≈ $95.38 Million	0.153x	-40.39%
2016-12-31	CN¥4.05 Billion ≈ $592.15 Million	CN¥1.04 Billion ≈ $152.26 Million	0.257x	+27.19%
2015-12-31	CN¥3.47 Billion ≈ $508.18 Million	CN¥702.05 Million ≈ $102.73 Million	0.202x	-6.96%
2014-12-31	CN¥3.10 Billion ≈ $453.95 Million	CN¥674.04 Million ≈ $98.63 Million	0.217x	+18.87%
2013-12-31	CN¥2.48 Billion ≈ $362.66 Million	CN¥453.02 Million ≈ $66.29 Million	0.183x	+109.59%
2012-12-31	CN¥2.36 Billion ≈ $345.46 Million	CN¥205.89 Million ≈ $30.13 Million	0.087x	+49.01%
2011-12-31	CN¥2.20 Billion ≈ $321.54 Million	CN¥128.61 Million ≈ $18.82 Million	0.059x	+10.24%
2010-12-31	CN¥2.12 Billion ≈ $310.33 Million	CN¥112.59 Million ≈ $16.48 Million	0.053x	-91.06%
2009-12-31	CN¥287.53 Million ≈ $42.07 Million	CN¥170.82 Million ≈ $25.00 Million	0.594x	+99.41%
2008-12-31	CN¥194.04 Million ≈ $28.39 Million	CN¥57.81 Million ≈ $8.46 Million	0.298x	-21.12%
2007-12-31	CN¥138.36 Million ≈ $20.25 Million	CN¥52.26 Million ≈ $7.65 Million	0.378x	--

About Harbin Gloria Pharmaceuticals

SHE:002437 China Drug Manufacturers - Specialty & Generic

Market Cap

$975.64 Million

CN¥6.67 Billion CNY

Market Cap Rank

#8734 Global

#2034 in China

Share Price

CN¥2.99

Change (1 day)

+2.75%

52-Week Range

CN¥2.43 - CN¥4.98

All Time High

CN¥11.06